Clinical Trial Update: Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases [Phase 1]

View source ↗

Summary

A Phase 1 study of trastuzumab deruxtecan in combination with stereotactic radiosurgery for HER2-positive breast cancer with brain metastases; the trial is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING